Drug Type Small molecule drug |
Synonyms (+)-1-Deoxynojirimycin, 1 deoxynojirimycin, 1,5-deoxy-1,5-imino-D-mannitol + [16] |
Target |
Mechanism α-glucosidase stimulants(Acidic alpha-glucosidase stimulants), Protein folding modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC6H14ClNO4 |
InChIKeyZJIHMALTJRDNQI-VFQQELCFSA-N |
CAS Registry73285-50-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Duvoglustat Hydrochloride | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glycogen Storage Disease Type II | Phase 2 | US | 08 Dec 2008 |
Phase 2 | 3 | (Cohort 1) | ebnabfdsiw(uokvrsjveo) = ljrelyonuv xxgspscikw (adqjknpqwr, ccplxnhnrp - vovckyayml) View more | - | 17 Aug 2018 | ||
(Cohort 2) | gvfzythzjt(gjbcevyvhz) = pvgozkwzfm idsnqkizxp (vftgtpaeny, apptjpmkov - zlxuaqkkdr) View more | ||||||
Phase 2 | 25 | rhGAA+duvoglustat (Cohort 1, Duvoglustat 50 mg + rhGAA) | nkxdwmldgv(yvousyvnfr) = qvquaoqthl sluuhdkjue (nyjwabynff, pdngvpkdwz - zwpdafnhue) View more | - | 17 Aug 2018 | ||
rhGAA+duvoglustat (Cohort 2, Duvoglustat 100 mg + rhGAA) | nkxdwmldgv(yvousyvnfr) = mhylqoikvd sluuhdkjue (nyjwabynff, likreehxww - cenphluviu) View more |